Cargando…

Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania

BACKGROUND: The severity of malaria infection depends on the host, parasite and environmental factors. Merozoite surface protein (msp) diversity determines transmission dynamics, P. falciparum immunity evasion, and pathogenesis or virulence. There is limited updated information on P. falciparum msp...

Descripción completa

Detalles Bibliográficos
Autores principales: Marwa, Karol J., Lyimo, Eric, Konje, Eveline T., Kapesa, Anthony, Kamugisha, Erasmus, Swedberg, Göte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712017/
https://www.ncbi.nlm.nih.gov/pubmed/36467715
http://dx.doi.org/10.1155/2022/5089143
_version_ 1784841705356263424
author Marwa, Karol J.
Lyimo, Eric
Konje, Eveline T.
Kapesa, Anthony
Kamugisha, Erasmus
Swedberg, Göte
author_facet Marwa, Karol J.
Lyimo, Eric
Konje, Eveline T.
Kapesa, Anthony
Kamugisha, Erasmus
Swedberg, Göte
author_sort Marwa, Karol J.
collection PubMed
description BACKGROUND: The severity of malaria infection depends on the host, parasite and environmental factors. Merozoite surface protein (msp) diversity determines transmission dynamics, P. falciparum immunity evasion, and pathogenesis or virulence. There is limited updated information on P. falciparum msp polymorphisms and their impact on artemether-lumefantrine treatment outcomes in Tanzania. Therefore, this study is aimed at examining msp genetic diversity and multiplicity of infection (MOI) among P. falciparum malaria patients. The influence of MOI on peripheral parasite clearance and adequate clinical and parasitological response (ACPR) was also assessed. METHODS: Parasite DNA was extracted from dried blood spots according to the manufacture's protocol. Primary and nested PCR were performed. The PCR products for both the block 2 region of msp1 and the block 3 regions of msp2 genes and their specific allelic families were visualized on a 2.5% agarose gel. RESULTS: The majority of the isolates, 58/102 (58.8%) for msp1 and 69/115 (60.1%) for msp2, harboured more than one parasite genotypes. For the msp1 gene, K1 was the predominant allele observed (75.64%), whereas RO33 occurred at the lowest frequency (43.6%). For the msp2 gene, the 3D7 allele was observed at a higher frequency (81.7%) than the FC27 allele (76.9%). The MOIs were 2.44 for msp1 and 2.27 for msp2 (p = 0.669). A significant correlation between age and multiplicity of infection (MOI) for msp1 or MOI for msp2 was not established in this study (rho = 0.074, p = 0.521 and rho = −0.129, p = 0.261, respectively). Similarly, there was no positive correlation between parasite density at day 1 and MOI for both msp1 (rho = 0.113, p = 0.244) and msp2 (rho = 0.043, p = 0.712). The association between MOI and ACPR was not observed for either msp1 or mps2 (p = 0.776 and 0.296, respectively). CONCLUSIONS: This study reports high polyclonal infections, MOI and allelic frequencies for both msp1 and msp2. There was a lack of correlation between MOI and ACPR. However, a borderline significant correlation was observed between day 2 parasitaemia and MOI.
format Online
Article
Text
id pubmed-9712017
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-97120172022-12-01 Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania Marwa, Karol J. Lyimo, Eric Konje, Eveline T. Kapesa, Anthony Kamugisha, Erasmus Swedberg, Göte J Trop Med Research Article BACKGROUND: The severity of malaria infection depends on the host, parasite and environmental factors. Merozoite surface protein (msp) diversity determines transmission dynamics, P. falciparum immunity evasion, and pathogenesis or virulence. There is limited updated information on P. falciparum msp polymorphisms and their impact on artemether-lumefantrine treatment outcomes in Tanzania. Therefore, this study is aimed at examining msp genetic diversity and multiplicity of infection (MOI) among P. falciparum malaria patients. The influence of MOI on peripheral parasite clearance and adequate clinical and parasitological response (ACPR) was also assessed. METHODS: Parasite DNA was extracted from dried blood spots according to the manufacture's protocol. Primary and nested PCR were performed. The PCR products for both the block 2 region of msp1 and the block 3 regions of msp2 genes and their specific allelic families were visualized on a 2.5% agarose gel. RESULTS: The majority of the isolates, 58/102 (58.8%) for msp1 and 69/115 (60.1%) for msp2, harboured more than one parasite genotypes. For the msp1 gene, K1 was the predominant allele observed (75.64%), whereas RO33 occurred at the lowest frequency (43.6%). For the msp2 gene, the 3D7 allele was observed at a higher frequency (81.7%) than the FC27 allele (76.9%). The MOIs were 2.44 for msp1 and 2.27 for msp2 (p = 0.669). A significant correlation between age and multiplicity of infection (MOI) for msp1 or MOI for msp2 was not established in this study (rho = 0.074, p = 0.521 and rho = −0.129, p = 0.261, respectively). Similarly, there was no positive correlation between parasite density at day 1 and MOI for both msp1 (rho = 0.113, p = 0.244) and msp2 (rho = 0.043, p = 0.712). The association between MOI and ACPR was not observed for either msp1 or mps2 (p = 0.776 and 0.296, respectively). CONCLUSIONS: This study reports high polyclonal infections, MOI and allelic frequencies for both msp1 and msp2. There was a lack of correlation between MOI and ACPR. However, a borderline significant correlation was observed between day 2 parasitaemia and MOI. Hindawi 2022-11-23 /pmc/articles/PMC9712017/ /pubmed/36467715 http://dx.doi.org/10.1155/2022/5089143 Text en Copyright © 2022 Karol J. Marwa et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Marwa, Karol J.
Lyimo, Eric
Konje, Eveline T.
Kapesa, Anthony
Kamugisha, Erasmus
Swedberg, Göte
Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania
title Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania
title_full Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania
title_fullStr Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania
title_full_unstemmed Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania
title_short Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania
title_sort plasmodium falciparum merozoite surface proteins polymorphisms and treatment outcomes among patients with uncomplicated malaria in mwanza, tanzania
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712017/
https://www.ncbi.nlm.nih.gov/pubmed/36467715
http://dx.doi.org/10.1155/2022/5089143
work_keys_str_mv AT marwakarolj plasmodiumfalciparummerozoitesurfaceproteinspolymorphismsandtreatmentoutcomesamongpatientswithuncomplicatedmalariainmwanzatanzania
AT lyimoeric plasmodiumfalciparummerozoitesurfaceproteinspolymorphismsandtreatmentoutcomesamongpatientswithuncomplicatedmalariainmwanzatanzania
AT konjeevelinet plasmodiumfalciparummerozoitesurfaceproteinspolymorphismsandtreatmentoutcomesamongpatientswithuncomplicatedmalariainmwanzatanzania
AT kapesaanthony plasmodiumfalciparummerozoitesurfaceproteinspolymorphismsandtreatmentoutcomesamongpatientswithuncomplicatedmalariainmwanzatanzania
AT kamugishaerasmus plasmodiumfalciparummerozoitesurfaceproteinspolymorphismsandtreatmentoutcomesamongpatientswithuncomplicatedmalariainmwanzatanzania
AT swedberggote plasmodiumfalciparummerozoitesurfaceproteinspolymorphismsandtreatmentoutcomesamongpatientswithuncomplicatedmalariainmwanzatanzania